N-(2-Methyl-5-nitrophenyl)-4-(pyridin-3-yl)pyrimidin-2-amine CAS 152460-09-8 Imatinib Mesylate Intermediate High Purity
Ubonelelo ngezoRhwebo i-Imatinib Mesylate kunye nabaPhakathi abaNxulumeneyo:
I-Imatinib Mesylate CAS: 220127-57-1
N-(2-Methyl-5-nitrophenyl)-4-(pyridin-3-yl)pyrimidin-2-amine CAS: 152460-09-8
N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidinea CAS: 152460-10-1
4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride CAS: 106261-49-8
Igama leMchiza | N-(2-Methyl-5-nitrophenyl)-4-(pyridin-3-yl)pyrimidin-2-amine |
Izithethantonye | I-Imatinib Mesylate ePhakathi;2-(2-Methyl-5-nitroanilino)-4-(3-pyridyl)pyrimidine |
Inombolo yeCAS | 152460-09-8 |
Inombolo yeCAT | RF-PI228 |
Ubume beStokhwe | Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni |
Ifomula yeemolekyuli | I-C16H13N5O2 |
Ubunzima beMolekyuli | 307.31 |
Indawo yokunyibilika | 188.0 ~ 193.0℃ |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | Umgubo oMthubi okanye ophantse watyheli |
Ubunyulu | ≥98.0% (HPLC) |
Ukufuma (KF) | ≤0.50% |
Ukungcola ngokupheleleyo | ≤2.0% |
Ukungacoceki okuphezulu okukodwa | ≤1.0% |
Intsalela ekutshisweni | ≤0.50% |
Iintsimbi ezinzima | ≤20ppm |
Umgangatho woVavanyo | Umgangatho woShishino |
Ukusetyenziswa | Phakathi kwe-Imatinib Mesylate (CAS: 220127-57-1) |
Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, igubu lekhadibhodi, 25kg/Igubu, okanye ngokwemfuno yomthengi.
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ekukhanyeni, ukufuma kunye nokuhlaselwa zizinambuzane.
![1](https://a395.goodao.net/uploads/15.jpg)
![](https://a395.goodao.net/uploads/23.jpg)
I-Shanghai Ruifu Chemical Co., Ltd. ngumenzi ohamba phambili kunye nomthengisi we-N- (2-Methyl-5-nitrophenyl) -4- (pyridin-3-yl) pyrimidin-2-amine (CAS: 152460-09-8) ngomgangatho ophezulu.Yinto ephakathi ngokuqhelekileyo kwi-synthesis ye-Imatinib Mesylate (CAS: 220127-57-1).
I-Imatinib Mesylate yi-molecule encinci evimbela i-c-Abl protein-tyrosine kinase, I-Highly specific for BCR-ABL, i-enzyme ehambelana ne-chronic myelogenous leukemia (CML) kunye neendlela ezithile ze-acute lymphoblastic leukemia (ALL).Isiganeko sokudluliselwa phakathi kwe-chromosomes 9 kunye ne-22 ivelisa i-chromosome yasePhiladelphia, ethi emva koko ivelise iprotheni ye-Bcr-Abl ye-fusion kunye nomsebenzi we-aberrant kinase okhuthaza ukwanda kweeseli ngokukhawuleza.I-Imatinib Mesylate ibophelela le kinase ibalulekileyo, imisa ukukhula okunxulumene ne-CML.I-Imatinib Mesylate iye yaboniswa ngakumbi ukuvimbela i-PDGFR kunye ne-tyrosine kinases ehambelana ne-c-Kit.Iifomyula eziqulethe i-Imatinib Mesylate zisetyenziswe kunyango lwee-cancer ezahlukeneyo.